Abeona Therapeutics

(NASDAQ) ABEO

Current Price$5.43

Market Cap$309.78M

Since IPO (1996)-100%

5 Year-88%

1 Year-21%

1 Month+19%

Abeona Therapeutics Financials at a Glance

Market Cap

$309.78M

Revenue (TTM)

$5.82M

Net Income (TTM)

$71.18M

EPS (TTM)

$1.00

P/E Ratio

5.45

Dividend

$0.00

Beta (Volatility)

0.92 (Low)

Dividend

$0.00

Beta (Volatility)

0.92 (Low)

Price

$5.43

Volume

769,111.726

Open

$5.46

Price

$5.43

Volume

769,111.726

Open

$5.46

Previous Close

$5.43

Daily Range

$5.40 - $5.53

52-Week Range

$4.00 - $7.54

Dividend

$0.00

Beta (Volatility)

0.92 (Low)

Price

$5.43

Volume

769,111.726

Open

$5.46

Previous Close

$5.43

Daily Range

$5.40 - $5.53

52-Week Range

$4.00 - $7.54

ABEO News

Here's Why Abeona Therapeutics Popped Higher Today

Lee SamahaNov 12, 2025

Page 1

ABEO: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Abeona Therapeutics

Industry

Biotechnology

Sector

Health Care

Employees

226

CEO

Vishwas Seshadri, PhD, MBA

Website

www.abeonatherapeutics.com

Headquarters

Cleveland, NY 10019, US

ABEO Financials

Key Financial Metrics (TTM)

Gross Margin

26%

Operating Margin

-15%

Net Income Margin

12%

Return on Equity

70%

Return on Capital

-47%

Return on Assets

32%

Earnings Yield

18.35%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$309.78M

Shares Outstanding

57.05M

Volume

769.11K

Avg. Volume

1.15M

Financials (TTM)

Gross Profit

$4.29M

Operating Income

$89.45M

EBITDA

$85.89M

Operating Cash Flow

$76.33M

Capital Expenditure

$7.97M

Free Cash Flow

$84.30M

Cash & ST Invst.

$191.40M

Total Debt

$24.97M

Abeona Therapeutics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

$5.42M

N/A

Gross Profit

$1.72M

+321.6%

Gross Margin

31.73%

N/A

Market Cap

$309.78M

N/A

Market Cap/Employee

$2.28M

N/A

Employees

136

N/A

Net Income

$20.46M

-120.2%

EBITDA

$183.17M

-2363.0%

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Net Cash

$166.44M

+122.9%

Accounts Receivable

$6.71M

+306.5%

Inventory

$5.49M

N/A

Long Term Debt

$11.88M

-27.1%

Short Term Debt

$13.09M

+93.9%

Return on Assets

32.42%

N/A

Return on Invested Capital

-47.08%

N/A

Free Cash Flow

$19.11M

-11.3%

Operating Cash Flow

$17.95M

-8.4%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

FHTXFoghorn Therapeutics Inc.

FHTXFoghorn Therapeutics Inc.$4.76+0.21%

ARCTArcturus Therapeutics Holdings Inc.

ARCTArcturus Therapeutics Holdings Inc.$8.63+0.12%

SGMTSagimet Biosciences Inc.

SGMTSagimet Biosciences Inc.$7.61-5.23%

PBYIPuma Biotechnology, Inc.

PBYIPuma Biotechnology, Inc.$7.49-0.27%

VYGRVoyager Therapeutics, Inc.

VYGRVoyager Therapeutics, Inc.$3.76+0.80%

ELDNEledon Pharmaceuticals, Inc.

ELDNEledon Pharmaceuticals, Inc.$3.69+1.37%

ASMBAssembly Biosciences, Inc.

ASMBAssembly Biosciences, Inc.$27.37+1.56%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$13.30+0.03%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.07+0.05%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.70+0.01%

SOFISoFi Technologies

SOFISoFi Technologies$16.43+0.02%

SOUNSoundHound AI

SOUNSoundHound AI$9.56+0.20%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$65.30+0.03%

NIONio

NIONio$5.91-0.08%

Questions About ABEO

What is the current price of Abeona Therapeutics?

Abeona Therapeutics is trading at $5.43 per share.

What is the 52-week range for Abeona Therapeutics?

Over the past 52 weeks, Abeona Therapeutics has traded between $4.00 and $7.54.

How much debt does Abeona Therapeutics have?

As of the most recent reporting period, Abeona Therapeutics reported total debt of $24.97M.

How much cash does Abeona Therapeutics have on hand?

Abeona Therapeutics reported $78.44M in cash and cash equivalents in its most recent financial results.

What is Abeona Therapeutics’s dividend yield?

Abeona Therapeutics does not currently have a dividend yield.

Abeona Therapeutics

Abeona Therapeutics Financials at a Glance

ABEO News

Here's Why Abeona Therapeutics Popped Higher Today

Abeona Posts Q2 Profit on Asset Sale

Here's Why Abeona Therapeutics Fell as Much as 43.8% Today

3 Small-Cap Biotech Stocks to Keep on Your Radar

Here's Why Abeona Therapeutics Stock Dropped 12% Today

3 Biotech Stocks That Soared This Week: Are They Buys?

Why Abeona Therapeutics Jumped 14% on Wednesday

Here's Why Abeona Therapeutics Inc. Stock Spiked Today

ABEO: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Abeona Therapeutics

ABEO Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Abeona Therapeutics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About ABEO

What is the current price of Abeona Therapeutics?

What is the 52-week range for Abeona Therapeutics?

How much debt does Abeona Therapeutics have?

How much cash does Abeona Therapeutics have on hand?

What is Abeona Therapeutics’s dividend yield?

Premium Investing Services